Cover Stories

Deceased-donor kidneys retrieved for transplantation are increasingly being discarded, and the most common reason given for discarding the kidneys is biopsy results.

Two new studies published in the Clinical Journal of the American Society of Nephrology suggest that procurement biopsies are not predictive of posttransplant outcomes and may only serve to dissuade the use of kidneys that are otherwise suitable for transplant. The findings suggest that other methods are needed when weighing whether to transplant a deceased-donor kidney.


A relatively new pair of biomarkers may give a valuable early signal of acute kidney injury (AKI), according to two papers, including a study that selected the pair from a competition with more than 300 potential candidates.

On Tuesday, November 12, 2013, Congress passed legislation that one day could allow individuals with HIV to receive organ transplants from deceased donors with HIV, expanding the total pool of available organs and reducing wait times. Nine days later, President Obama signed the act into law.

ASN made the HIV Organ Policy Equity (HOPE) Act a policy priority, and the society has aggressively pushed for passage of the bill since its introduction in February 2013.

Acute kidney injury is one of the most common and serious complications of hospitalized patients. Yet there are no FDA-approved therapies for this disorder except dialysis, and potential drug therapies are associated with a number of adverse effects.


A new report on sodium and health found recent evidence is insufficient to support recommended dietary intake levels. The Institute of Medicine (IOM) analysis—Sodium Intake in Populations: Assessment of Evidence—has ignited a debate about whether salt restriction is linked to health benefits, especially for at-risk individuals (1).


A new fluorescence visualization technique reveals that cilia admit much larger molecules than has previously been seen—a finding that could provide new insights into cell signaling systems from what could be an important new research tool.

<?xml version="1.0"?>
Elevated phosphate levels in the blood—even when levels are in the high normal range—carry increased heart-related risks, but taking a phosphate binder did not improve cardiovascular measures in patients with mild kidney disease in a recent study published in the Journal of the American Society of Nephrology.